Navigation Links
Minorities Less Likely to Use Hospice Care: Study
Date:6/29/2012

FRIDAY, June 29 (HealthDay News) -- Minority patients with heart failure are less likely to use hospice care than whites, new research finds.

Hospice provides palliative care for the terminally ill. The goal is to ease pain and discomfort, and to focus on quality of life as death approaches. Overall, use of hospice care is increasing, according to researchers from Indiana University School of Medicine.

Their study found that nonwhite Medicare patients with heart failure were 20 percent less likely to enroll in hospice than white patients. Nonwhite patients were also more likely to drop out of hospice care than whites.

"When considering end-of-life care options, it is important to consider hospice services at home, in nursing homes or in hospice facilities," study author Dr. Kathleen Unroe, a scientist with the Indiana University Center for Aging Research, said in a university news release. "Our findings highlight that there is a significant difference between how white patients and nonwhite patients and their families utilize hospice services."

The study, which looked at records on nearly 220,000 heart failure patients on Medicare, was published in the June issue of the American Heart Journal.

Nearly 1.6 million people received hospice services in 2010, according to the National Hospice and Palliative Care Organization. About 42 percent of all deaths in the United States were under the care of a hospice program in 2010.

More information

The U.S. National Institutes of Health provides more information on hospice care.

-- Mary Elizabeth Dallas

SOURCE: Indiana University School of Medicine, news release, June 25, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Minorities, Medicare Recipients Less Likely to Get Antidepressants
2. C-Section Babies May Be More Likely to Fail First Hearing Test
3. Car crash victims more likely to survive if taken directly to a trauma centre
4. Patients with PsA treated with ustekinumab are twice as likely to achieve acr20 vs. placebo
5. Depressed Teens Who Respond to Treatment Less Likely to Abuse Drugs
6. City kids more likely to have food allergies than rural ones
7. Patients taking certolizumab pegol are twice as likely to achievE ACR20 compared to placebo
8. Obese More Likely to Be Diagnosed With Advanced Thyroid Cancer
9. Genetic test identifies eye cancer tumors likely to spread
10. Individuals with dementia more likely to die at home than in nursing homes
11. Blacks Less Likely to Get Help on Scene After Cardiac Arrest: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... Reflections Recovery ... now accredited by The Joint Commission for chemical dependency and behavioral health services. ... U.S. health care organizations that meet the commission’s rigorous standards. Accreditation by The ...
(Date:9/20/2017)... , ... September 20, 2017 , ... ... Clinical Plus Coating System for clients that rely on safety and cleanliness. This ... of microorganisms. , Silver has been used for centuries for its antimicrobial properties. ...
(Date:9/20/2017)... ... 2017 , ... Renal Support Network’s annual essay contest celebrates ... The theme “Describe a positive decision that you have made about your healthcare” ... one qualification— to have been diagnosed with chronic kidney disease. This year the ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... medical device compliance and commercialization, has just released a new white paper ... is more adamant than ever about medical device, pharmaceutical, and combination product ...
(Date:9/20/2017)... ... September 20, 2017 , ... Demand generation pioneer ... East-coast edition of MarTech: The Marketing Tech Conference October 2–4, at the Hynes ... 40 speakers — representing such thought-leading companies as JP Morgan Chase, GE ...
Breaking Medicine News(10 mins):
(Date:9/5/2017)... -- Sapheneia and Scannerside received FDA 510(k) clearance to ... third-party Vendor neutral CT product that makes it affordable ... current MITA standards. ... specifically designed to provide CT operators, prior to a ... a predefined threshold. Scannerside Dose Check is intended to ...
(Date:9/5/2017)... Pharmaceuticals Inc. (NASDAQ: ORMP ) (TASE: ORMP) ... the development of oral drug delivery systems, announced today ... U.S. Food and Drug Administration (FDA) regarding ORMD-0801, the ... At the meeting, the FDA gave clear ... would be a Biologics License Application (BLA).  Such a ...
(Date:8/31/2017)... -- PM360,s annual Innovations Issue, published in December, ... happening across the industry. Established six years ago, this ... a comprehensive look at the newest and most exciting ... companies, startups, divisions, products, services, and strategies from the ... in this industry wants to do better—in all facets ...
Breaking Medicine Technology: